U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C11H17N5O2
Molecular Weight 251.285
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DIMETHAZAN

SMILES

CN(C)CCN1C=NC2=C1C(=O)N(C)C(=O)N2C

InChI

InChIKey=CMKUGKVVUUGBHJ-UHFFFAOYSA-N
InChI=1S/C11H17N5O2/c1-13(2)5-6-16-7-12-9-8(16)10(17)15(4)11(18)14(9)3/h7H,5-6H2,1-4H3

HIDE SMILES / InChI

Molecular Formula C11H17N5O2
Molecular Weight 251.285
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Dimethazan is a caffeine derivative. Dimethazan differs from caffeine by the replacement of the third methyl group. Dimethazan possesses antidepressant and diuretic properties. Dimethazan, administered intravenously to geriatric patients, produced respiratory and cerebral stimulation in the majority of cases. The clinical utilization of the respiratory stimulatory effect was confirmed in a patient markedly depressed with chlorpromazine. Oral administration to patients hospitalized for treatment of mental and physical depression indicated a dual effect: central nervous system stimulation and sedation. It is safe and well tolerated with none of the shortcomings of other caffeine preparations.

Approval Year

PubMed

Sample Use Guides

In Vivo Use Guide
50 to 600 mg over a 2- to 4-minute period
Route of Administration: Intravenous
Substance Class Chemical
Record UNII
H943V308AD
Record Status Validated (UNII)
Record Version